MacroGenics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -163.8% | – | – | – | – | -183.2% | – | – | |
| – | -2.6% | -3.1% | -1.6% | +1.3% | +11.9% | -13.7% | +7.7% | -6.2% | -13.1% | +8.6% | -128.1% | – | |
| – | -9.0% | +27.4% | +19.8% | -10.2% | +88.7% | -61.1% | -15.9% | -3.8% | -25.0% | -0.6% | -25.4% | – | |
| – | – | -101.5% | – | -236.0% | – | -565.1% | – | – | – | -103.3% | – | – | |
| – | +24.2% | +135.3% | -29.1% | -42.8% | +4.7% | -14.7% | +35.2% | -40.4% | -42.7% | +41.0% | +134.3% | – | |
| – | – | -36.1% | +91.3% | -25.0% | +16.5% | -76.1% | -480.1% | -45.9% | +223.9% | – | -38.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.5% | -9.2% | +152.0% | -110.9% | – | -281.9% | – | -100.0% | – | -463.2% | – | – | |
| – | – | -286.3% | – | +2,575.2% | -96.6% | -1,259.3% | – | – | – | – | +409.6% | – | |
| – | – | – | – | – | -165.5% | – | – | – | – | -184.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.